National Medicines Policy Review – publication of submissions

21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...

Read more →

NICE moves: increased accessibility and flexibility for health tech

19 January 2022 - NICE also aims to make strides in digital, genomic and antimicrobial technologies ...

Read more →

UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile

19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...

Read more →

Early benefit assessment for new drugs 2021: G-BA sets a record with 146 completed procedures

10 January 2022 - At the beginning of the year, the Federal Joint Committee (G-BA) took stock of its assessment of ...

Read more →

TGA in review (2021)

19 January 2022 - Using a liberal definition of what constitutes a 'new medicine', we have determined the TGA approved ...

Read more →

FDA approved more first in class drugs, gave more accelerated approvals in 2021

7 January 2022 - The US Food and Drug Administration’s Center for Drug Evaluation and Research approved 50 new drug therapies ...

Read more →

PHARMAC’s year in review

20 December 2021 - Today PHARMAC has released its Year in Review for 2021, an annual publication highlighting key aspects of ...

Read more →

‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit

10 December 2021 - It was the day before Christmas in 2015 and a senior director of national accounts at ...

Read more →

Shining a light on PHARMAC

6 December 2021 - It is encouraging to read the country’s drug buying agency PHARMAC is already moving to improve ...

Read more →

Reforms needed for FDA’s regulation of medical devices

3 December 2021 - Medical devices are mainstays of modern medicine, from basic products like gloves and bandages to complex ...

Read more →

PHARMAC review: 'Damning' interim report reveals 'fortress mentality', Māori, equity progress slow

2 December 2021 - An interim report of a major PHARMAC review has slated the Government drug buying agency over ...

Read more →

PHARMAC welcomes interim report

 2 December 2021 - PHARMAC accepts many of the observations made in the Interim Report and is already making changes ...

Read more →

Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology

25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...

Read more →

MTAA welcomes new frontiers report

25 November 2021 - The Medical Technology Association of Australia wishes to thank Trent Zimmerman MP and Dr Mike Freelander MP ...

Read more →

Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies

25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...

Read more →